These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 18580671

  • 21. Best evidence topic reports. Does nimodipine reduce mortality and secondary ischaemic events after subarachnoid haemorrhage?
    Brown G, Carley S.
    Emerg Med J; 2004 May; 21(3):333. PubMed ID: 15107373
    [Abstract] [Full Text] [Related]

  • 22. Aneurysmal Subarachnoid Hemorrhage: Strategies for Preventing Vasospasm in the Intensive Care Unit.
    Diringer MN, Zazulia AR.
    Semin Respir Crit Care Med; 2017 Dec; 38(6):760-767. PubMed ID: 29262433
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine.
    Zhao J, Zhou D, Guo J, Ren Z, Zhou L, Wang S, Zhang Y, Xu B, Zhao K, Wang R, Mao Y, Xu B, Zhang X, Fasudil Aneurysmal Subarachnoid Hemorrhage Study Group.
    Neurol Med Chir (Tokyo); 2011 Dec; 51(10):679-83. PubMed ID: 22027241
    [Abstract] [Full Text] [Related]

  • 24. Nimodipine-associated standard dose reductions and neurologic outcomes after aneurysmal subarachnoid hemorrhage: the era of pharmacogenomics.
    Vázquez-Medina A, Turnbull MT, James CL, Cowart JB, Lesser E, Carter RE, Ross OA, Miller DA, Meschia JF, De Jesús Espinosa A, Weinshilboum R, Freeman WD.
    Pharmacogenomics J; 2024 Jun 18; 24(4):19. PubMed ID: 38890281
    [Abstract] [Full Text] [Related]

  • 25. Calcium antagonists in the management of subarachnoid haemorrhage.
    Robinson MJ, Teasdale GM.
    Cerebrovasc Brain Metab Rev; 1990 Jun 18; 2(3):205-26. PubMed ID: 2223432
    [Abstract] [Full Text] [Related]

  • 26. [Vascular and neuronal mechanisms of calcium antagonists. Significance in neurological therapy].
    Govoni S, Trabucchi M, Battaini F, Magnoni MS, Paoletti R.
    Minerva Med; 1986 Jun 08; 77(24):1053-8. PubMed ID: 3725133
    [Abstract] [Full Text] [Related]

  • 27. Nimodipine and its use in cerebrovascular disease: evidence from recent preclinical and controlled clinical studies.
    Tomassoni D, Lanari A, Silvestrelli G, Traini E, Amenta F.
    Clin Exp Hypertens; 2008 Nov 08; 30(8):744-66. PubMed ID: 19021025
    [Abstract] [Full Text] [Related]

  • 28. Pharmacological Prevention of Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage.
    Caylor MM, Macdonald RL.
    Neurocrit Care; 2024 Feb 08; 40(1):159-169. PubMed ID: 37740138
    [Abstract] [Full Text] [Related]

  • 29. Dangers of outpatient nimodipine use after spontaneous subarachnoid hemorrhage in accordance with the Comprehensive Stroke Center guidelines.
    Chen CJ, Turnage C, Sokolowski JD, Kumar JS, Kalani MY, Park MS.
    J Clin Neurosci; 2018 Jun 08; 52():151-152. PubMed ID: 29656002
    [Abstract] [Full Text] [Related]

  • 30. Clinical experience of selective intra-arterial nimodipine treatment for cerebral vasospasm following subarachnoid hemorrhage.
    Biondi A, Le Jean L, Puybasset L.
    AJNR Am J Neuroradiol; 2006 Mar 08; 27(3):474; author reply 474. PubMed ID: 16551980
    [No Abstract] [Full Text] [Related]

  • 31. Continuous selective intraarterial infusion of nimodipine for therapy of refractory cerebral vasospasm.
    Wolf S, Martin H, Landscheidt JF, Rodiek SO, Schürer L, Lumenta CB.
    Neurocrit Care; 2010 Jun 08; 12(3):346-51. PubMed ID: 20033353
    [Abstract] [Full Text] [Related]

  • 32. [Diagnosis and treatment of subarachnoid hemorrhage].
    Nader J, Flores F, Ibarra O, Mejía A, Neri G, Rangel R, Rodríguez J, Araúz A, Cantú C, Barinagarrementeria F.
    Rev Invest Clin; 2002 Jun 08; 54(3):281-4. PubMed ID: 12183900
    [No Abstract] [Full Text] [Related]

  • 33. [Treatment of subarachnoid hemorrhage].
    Ohman J.
    Duodecim; 1994 Jun 08; 110(5):511-5. PubMed ID: 7555846
    [No Abstract] [Full Text] [Related]

  • 34. Nimodipine for traumatic [corrected] subarachnoid haemorrhage: the end of the road or better trials?
    Sen J, Belli A.
    Lancet Neurol; 2006 Dec 08; 5(12):993-4. PubMed ID: 17110273
    [No Abstract] [Full Text] [Related]

  • 35. Calcium antagonists for the treatment of vasospasm following subarachnoid haemorrhage.
    Hongo K, Kobayashi S.
    Neurol Res; 1993 Aug 08; 15(4):218-24. PubMed ID: 8105400
    [Abstract] [Full Text] [Related]

  • 36. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3. Elevation of serum magnesium may improve clinical outcome after aneursymal subarachnoid haemorrhage.
    Horner D.
    Emerg Med J; 2011 Feb 08; 28(2):166-8. PubMed ID: 21239426
    [No Abstract] [Full Text] [Related]

  • 37. Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)].
    Hänggi D, Etminan N, Mayer SA, Aldrich EF, Diringer MN, Schmutzhard E, Faleck HJ, Ng D, Saville BR, Macdonald RL, NEWTON Investigators.
    Neurocrit Care; 2019 Feb 08; 30(1):88-97. PubMed ID: 30014184
    [Abstract] [Full Text] [Related]

  • 38. [Endovascular treatment of vasospasm following subarachnoid aneurysmal haemorrhage].
    Abdennour L, Lejean L, Bonneville F, Boch AL, Puybasset L.
    Ann Fr Anesth Reanim; 2007 Nov 08; 26(11):985-9. PubMed ID: 17935940
    [Abstract] [Full Text] [Related]

  • 39. Hypoxemia associated with nimodipine in a patient with an aneurysmal subarachnoid hemorrhage.
    Baker M, Bastin MT, Cook AM, Fraser J, Hessel E.
    Am J Health Syst Pharm; 2015 Jan 01; 72(1):39-43. PubMed ID: 25511836
    [Abstract] [Full Text] [Related]

  • 40. Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral vasospasm in the rat double subarachnoid hemorrhage model.
    Hänggi D, Eicker S, Beseoglu K, Rapp M, Perrin J, Nawatny J, Turowski B, Sommer C, Steiger HJ.
    Neurosurgery; 2009 Jun 01; 64(6):1155-9; discussion 1159-61. PubMed ID: 19487896
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.